PCOS Explained: Symptoms, Causes and What Moves the Needle

PCOS is diagnosed on two of three Rotterdam criteria, and insulin resistance drives most cases. What helps, and which long-term risks to screen for.

PCOS is a metabolic and hormonal condition, diagnosed when you meet two of three Rotterdam criteria: irregular ovulation, high androgens, or polycystic ovaries on ultrasound. Insulin resistance drives most cases, which is why the interventions that work are metabolic rather than reproductive. Here is what the evidence supports, and what it does not.

🩺
Medically reviewed by Dr. A. Collins, MD · Board Certified Internist Reviewed October 2026 · 11 min read
2 of 3criteria needed for a Rotterdam diagnosis
4phenotypes in current classification
12follicles on one ovary that meet the ovarian criterion
2003year the Rotterdam criteria were published
💡 Short answer: PCOS is diagnosed on two of three Rotterdam criteria, and insulin resistance is the mechanism behind most cases. The interventions with the best evidence are unglamorous: weight loss where it is achievable, resistance training, protecting sleep timing, and inositol at the ratios that were actually studied. None of it cures PCOS, and any plan that promises a cure is selling something.

🧬 What PCOS Actually Is

Polycystic ovary syndrome is diagnosed using the Rotterdam criteria, still the international reference point. Two of three findings are enough, and no single test is decisive. Rotterdam ESHRE/ASRM consensus, Human Reproduction, 2004

  • Irregular or absent ovulation — cycles longer than 35 days, fewer than eight periods a year, or none at all
  • Clinical or biochemical hyperandrogenism — raised testosterone on blood work, or visible signs such as excess facial hair, persistent acne or male-pattern thinning
  • Polycystic ovarian morphology — twelve or more follicles of 2–9 mm in one ovary, or ovarian volume above 10 mL

The name misleads. Those follicles are eggs that stalled before maturity, not cysts. Normally one follicle becomes dominant and ovulates; here that selection fails and small follicles accumulate. You can meet the criteria with completely normal ovaries.

What ties the three together is the signalling environment the ovary responds to, not the ovary itself. That is why one diagnosis covers a lean 22-year-old with acne and a 38-year-old with central weight gain and no periods. Christ, Diagnostics, 2023

📋 The Four Phenotypes: Not One Condition

Rotterdam defines the diagnosis; phenotypes describe which version you have. The distinction matters because metabolic risk and treatment priority differ between them. Lizneva, Fertility and Sterility, 2016

PhenotypeCriteria metTypical presentationMetabolic picture
A — classic All three Irregular cycles, clear androgen excess, polycystic ovaries Highest metabolic load; insulin testing matters most here
B — non-PCO Ovulation and androgen criteria Normal scan, so often dismissed as not real PCOS Risk remains; a clean ultrasound is not reassurance
C — ovulatory Androgen and ovarian criteria Regular periods, so the diagnosis is missed while acne and hair changes persist Lower fertility impact, same androgen burden
D — non-hyperandrogenic Ovulation and ovarian criteria Irregular cycles, normal androgens Generally milder, though not risk-free

Phenotype C is why “but my periods are regular” is not an answer. Phenotype B is why “but my scan was normal” is not one either. Women in both groups get told they do not qualify.

📈 What Causes PCOS? Insulin Resistance and Three Other Drivers

No single cause: a genetic predisposition that needs an environmental push, with four mechanisms doing most of the work.

Insulin resistance is the engine

In the majority of cases insulin resistance is present and upstream of the reproductive symptoms. When muscle, fat and liver respond poorly to insulin, the pancreas releases more. That excess drives ovarian theca cells to produce androgen and suppresses sex hormone-binding globulin, so more testosterone circulates unbound. Zhao, Journal of Ovarian Research, 2023

Hyperinsulinaemia and insulin resistance overlap without being identical, and a woman can have one without the other — which is why a normal fasting insulin does not close the question as neatly as it looks. Houston, Journal of Endocrinology, 2025

The LH/FSH imbalance. The pituitary releases luteinising hormone out of proportion to FSH. High LH pushes theca cells toward androgen production; relative FSH insufficiency means no follicle gets selected to ovulate. Anovulation then removes the progesterone that would reset the cycle, so the pattern sustains itself. Chan, Journal of Clinical Investigation, 2026

Low-grade inflammation. PCOS has been described as a systemic inflammatory endocrinopathy, with C-reactive protein and interleukin-6 raised even in women of normal weight. Inflammation impairs insulin signalling and insulin resistance promotes inflammation, so the loop runs both ways — the rationale for testing anti-inflammatory eating patterns at all. Patel, Journal of Steroid Biochemistry and Molecular Biology, 2018

Genetics. PCOS clusters in families, and first-degree relatives carry higher rates of both PCOS and metabolic syndrome, so family history belongs in the assessment. The case for chronic inflammation runs through the same biology.

⚡ Symptoms: More Than Irregular Periods

Two women with the same diagnosis can share almost no symptoms. The common threads:

  • Menstrual irregularity — cycles over 35 days, fewer than eight periods a year, or cycles that stop
  • Hirsutism — coarse hair on the face, chin, chest or abdomen, in a male pattern
  • Acne and oily skin — often along the jaw, often resistant to topical treatment
  • Androgenic alopecia — thinning at the crown and temples, frequently dismissed as stress
  • Central weight gain — abdominal fat driven by insulin signalling, not discipline
  • Fertility difficulty — anovulation makes conception unpredictable, not impossible
  • Mood and cognition — higher rates of anxiety and depression, and brain fog that tracks blood sugar

Hair thinning and mood are the two missed most often.

🔍 Why Does Diagnosis Take So Long?

The criteria are clear. The route to them is not, and four failures account for most of the delay.

  • Adolescent cycles are waved through. Irregularity is normal after menarche, but persistent anovulation beyond that is a finding, not a phase
  • The scan is treated as the test. Follicle counts vary with technique and with who reads the image, so a normal report does not exclude PCOS
  • Weight is treated as the diagnosis. Being told to lose weight is not a workup, and it delays the metabolic assessment
  • Other causes are not excluded. Thyroid dysfunction, high prolactin and non-classic adrenal hyperplasia all mimic parts of the picture

Guidance is explicit that PCOS is a diagnosis of exclusion as well as inclusion, so the tests ruling other conditions out are part of the diagnosis, not an extra. (Christ, Diagnostics, 2023)

💡 What to bring to the appointment Three months of cycle dates, any previous testosterone, LH, FSH, thyroid and prolactin results, a full supplement list including online purchases, and the family history of PCOS, type 2 diabetes and early heart disease. Then ask which of the three criteria you meet.

⚠️ The Long-Term Risks People Are Not Told

The reproductive symptoms get the appointment; the metabolic and endometrial consequences get a paragraph, if that. The consensus that defines the diagnosis also sets out the long-term risks, which is why PCOS is something to monitor, not endure. (Rotterdam consensus, Human Reproduction, 2004)

Long-term riskWhy it happensWhat monitoring looks like
Type 2 diabetes Insulin resistance is the mechanism, and glucose tolerance can already be impaired at diagnosis HbA1c or an oral glucose tolerance test at diagnosis, then on an agreed schedule
Cardiovascular risk factors Higher rates of dyslipidaemia, hypertension and metabolic syndrome, with central fat adding load Lipids and blood pressure at least annually
Endometrial hyperplasia Chronic anovulation means oestrogen without the monthly progesterone that sheds the lining Cyclical progestogen or combined contraception if periods are very infrequent; investigate unscheduled bleeding
Pregnancy complications Gestational diabetes and hypertensive disorders occur more often Early glucose testing and closer antenatal monitoring
Depression and anxiety More common than in the general population, and often attributed to the diagnosis itself Screening rather than waiting for a disclosure
🚫 The risk most often skipped If you have had fewer than four periods a year for years, raise the endometrial question explicitly. Unopposed oestrogen is a cumulative exposure, and the protection is straightforward: cyclical progestogen, a combined contraceptive, or a levonorgestrel intrauterine system. Not a reason to panic — a reason to have the conversation.

🏃 What Actually Moves the Needle?

Four interventions have meaningful human evidence. None is novel, and none is sold as a protocol.

Weight, with two corrections. Structured diet and exercise improve insulin sensitivity, cycle regularity and androgen measures, and the effect appears with modest loss rather than a target BMI. Gautam, Nutrients, 2025 PCOS makes weight loss harder, because insulin resistance drives fat storage and hunger, so willpower framing is both wrong and counterproductive. Lean PCOS is also real: a normal BMI does not rule out insulin resistance, which is why tracking glucose response says more than the scale.

Sleep timing, not sleep perfection. The evidence is thin: no trial of sleep extension in PCOS justifies a symptom claim. What is defensible is narrower. Sleep timing anchors the rest of the plan, and a consistent wake time survives a bad night.

  • Fix the wake time first — it sets circadian timing and holds better than a fixed bedtime
  • Get outdoor light early — the strongest available signal for shifting timing earlier
  • Protect the last hour — dim light and no screens beats most sleep supplements

Timing matters more than hours in bed (sleep architecture), and CBT-I is first-line if sleep has become the problem.

Wearable No subscription

Want to see your sleep timing instead of guessing at it?

The Ultrahuman Ring AIR tracks sleep stages, recovery readiness, movement and stress patterns, and ships with a free sizing kit. It is a tracker, not a treatment — it will not diagnose PCOS, but it shows whether the sleep part of your plan is happening.

Read the Ring AIR review →

$349 one-time · $0 per month · free sizing kit.

AllAboutHealthToday may receive a commission at no additional cost to you. The Ring AIR is a consumer wearable. It does not diagnose, treat or prevent any condition.

Resistance training beats another hour of cardio

Muscle is the largest glucose sink, so building it changes insulin sensitivity in a way cardio alone does not.

  • Two or three sessions a week — compound movements, progressive load, enough protein to support the adaptation
  • A ten to fifteen minute walk after meals — the cheapest way to blunt a post-meal glucose rise
  • Yoga once or twice a week — modest but consistent evidence for yoga on anxiety and androgen measures, with better adherence than most programmes

The highest-burn exercises are rarely the ones people keep doing.

Inositol: the best-studied supplement

Myo-inositol has more randomised evidence in PCOS than anything else on the shelf. A meta-analysis of controlled trials found improvements in ovulation and metabolic parameters, with the usual caveat: the trials were small and heterogeneous. Unfer, Endocrine Connections, 2017

Two details decide whether a product is the thing that was studied. The ratio matters: most protocols use 40:1 myo-inositol to D-chiro-inositol, and a tub that does not state its ratio is not that formulation. The comparator matters too, and a trial comparing myo-inositol plus metformin against metformin alone answers a more useful question than another placebo comparison. Nazirudeen, Clinical Endocrinology, 2023 Read that one yourself rather than trusting a summary, including this one.

💊 Do Supplements Help PCOS?

Some do something. None replaces the four interventions above, and the review literature is blunt about quality: many small trials, inconsistent doses, few measuring an outcome anyone would notice. Alesi, Advances in Nutrition, 2022

  • Vitamin D — deficiency is common in PCOS and correcting a low level is reasonable; it is not a stand-alone treatment. Test first; see what a deficiency looks like
  • Omega-3 — small trials, modest effects on triglycerides and androgen measures; not worth an expensive dose
  • Probiotics and prebiotics — early signals from small studies with inconsistent designs; promising is not proven Martinez Guevara, Nutrients, 2024
  • Anything sold as a hormone balancer — if the label names no compound, dose and ratio, there is nothing to evaluate
  • Third-party testing — the market is not reliably policed, so a batch certificate from an accredited lab is the minimum
⚠️ The interaction nobody checks Inositol is sold as gentle, but it is not inert and it interacts with diabetes medication and fertility treatment. Tell your prescriber what you take, including doses. Adding an insulin sensitiser to metformin without adjusting the dose is how blood sugar goes too low.

🩺 Medical Treatment: What Is Available

Medical treatment has two jobs: manage symptoms while lifestyle changes take effect, and address specific goals such as fertility or endometrial protection. Whether you are trying to conceive reorders the list. (Chan, Journal of Clinical Investigation, 2026)

  • Combined hormonal contraception — first-line for acne, hirsutism and cycle regulation when conception is not the goal; it suppresses ovarian androgen production and raises binding globulin
  • Metformin — an insulin sensitiser used off-label, with the strongest rationale in impaired glucose tolerance; extended-release forms reduce gastrointestinal effects
  • Letrozole — ovulation induction, and now the usual first choice ahead of clomiphene for women trying to conceive
  • Anti-androgens — spironolactone for hirsutism and acne when contraception is in place, since it is not safe in pregnancy

What is missing from most consultations is sequencing: which problem is treated first, what the endpoint looks like, and when to stop. A plan without a review date is not a plan.

Verdict: what the evidence actually supports

A metabolic-first plan, with medical treatment for the symptoms it does not cover. The mechanism is well established, the lifestyle evidence is consistent if unspectacular, and inositol is the one supplement with enough randomised data to take seriously. What the evidence does not support is that any single intervention reverses PCOS, or that a normal BMI rules the metabolic problem out.

7.5
/ 10 — strength of evidence for the metabolic-first approach
Circadian timing Code RETIMER15

Shifting sleep timing without guessing at light exposure

Retimer 3 glasses deliver timed blue-green light to help move circadian timing earlier or later. That is a sleep-timing tool — not a treatment for insomnia, depression or PCOS.

See the Retimer 3 review →

15% off with code RETIMER15.

AllAboutHealthToday may receive a commission at no additional cost to you. Retimer glasses are a light-exposure device for circadian timing; they are not a treatment for any medical condition.

❓ Frequently Asked Questions

No. It can be managed well enough that cycles regularise and symptoms fade, but the predisposition stays. That is why the plan includes monitoring rather than a course of treatment with an end date.

No. Two of three findings are enough, and polycystic morphology is only one. The “cysts” are immature follicles, and a normal ultrasound does not rule the diagnosis out.

Yes. Anovulation makes timing unpredictable rather than impossible, and ovulation induction with letrozole is effective for many women. Say at the first appointment that conception is the goal.

No. It is classified as an endocrine and metabolic disorder. Thyroid function is still worth testing, because symptoms overlap, but the two are separate conditions.

It can improve insulin sensitivity, cycle regularity and androgen measures, and it is not a cure. The relationship runs both ways: insulin resistance makes weight loss harder, which is why “eat less” fails so often. Lean PCOS exists, so a normal BMI proves nothing.

Yes. That is phenotype C: hyperandrogenism plus polycystic morphology with ovulation intact. It is the phenotype most often missed, because the complaint is acne or hair change and the cycle gives no hint.

Sources

  1. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Human Reproduction, 2004. PMID 14688154
  2. Lizneva D, et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertility and Sterility, 2016. PMID 27233760
  3. Christ JP, et al. Current guidelines for diagnosing PCOS. Diagnostics, 2023. PMID 36980421
  4. Zhao H, et al. Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. Journal of Ovarian Research, 2023. PMID 36631836
  5. Houston EJ, et al. Reappraising the relationship between hyperinsulinemia and insulin resistance in PCOS. Journal of Endocrinology, 2025. PMID 40013621
  6. Chan JL, et al. Polyendocrine metabolic ovarian syndrome (PMOS)/polycystic ovary syndrome (PCOS): current and future trends. Journal of Clinical Investigation, 2026. PMID 42294900
  7. Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. Journal of Steroid Biochemistry and Molecular Biology, 2018. PMID 29678491
  8. Gautam R, et al. The role of lifestyle interventions in PCOS management: a systematic review. Nutrients, 2025. PMID 39861440
  9. Alesi S, et al. Nutritional supplements and complementary therapies in polycystic ovary syndrome. Advances in Nutrition, 2022. PMID 34970669
  10. Unfer V, et al. Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocrine Connections, 2017. PMID 29042448
  11. Nazirudeen R, et al. A randomized controlled trial comparing myoinositol with metformin versus metformin monotherapy in polycystic ovary syndrome. Clinical Endocrinology, 2023. PMID 37265016
  12. Martinez Guevara D, et al. Effectiveness of probiotics, prebiotics, and synbiotics in managing insulin resistance and hormonal imbalance in women with PCOS: a systematic review. Nutrients, 2024. PMID 39599701
All About Health Today
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.